Post by Nordic Biomarker

We are pleased to announce that Nordic Biomarker has appointed Jonas Wahlqvist as CEO, effective 1 June. Jonas succeeds Rikard Rodén, who has successfully led the company since 2016 and will remain with Nordic Biomarker during a transition period. Jonas joined Nordic Biomarker as Sales and Marketing Director in January 2024 and has played a key role in strengthening our commercial efforts and accelerating our international expansion. He brings broad strategic experience from McKinsey & Company, combined with a strong track record of leadership and entrepreneurial roles within digital and technology-enabled businesses. We look forward to this next chapter and continued growth together.   👉 Read more on our website: Nordic Biomarker appoints Jonas Wahlqvist as new CEO - Nordic Biomarker